Hyogen® Superior Enzootic Pneumonia Protection provides active immunization of healthy pigs against Mycoplasma hyopneumoniae.

Available in :

  • 100 ml
  • 200 ml
Contact us

Product information

Enzootic Pneumonia caused by Mycoplasma hyopneumoniae: HYOGEN® is the unique inactivated vaccine that offers strong fast and long lasting protection  by using just ONE dose (2 ml) in the life time of market pigs. This is due to its main components; the antigen originated from Ceva M. hyo strain BA 2940-99 along with the adjuvant, ImuvantTM. ImuvantTM is a unique Ceva adjuvant composed of a non-toxic lipopolysaccharide (LPS) from J5 E. coli together with a mineral oil in water emulsion that forms a complex and highly efficient immunostimulant. These components and balance formulation will enable and appropriate innate, humoral and cell-mediated immun response from the host.

Why choose Hyogen®?

Superior protection

One shot at weaning gives early and long-lasting protection

Supported by the CEVA Lung Program (less lung lesions)

The Science behind

Different local, innate and adaptive immune responses are induced by two commercial Mycoplasma hyopneumoniae bacterins and an adjuvant alone

Lisa Beuckelaere, Maarten Haspeslagh, Evelien Biebaut, Filip Boyen, Freddy Haesebrouck, Roman Krejci, Evelyne Meyer, David Gleerup, Ward De Spiegelaere, Bert Devriendt and Dominiek Maes

Different-local-inna (4.88 MB)Download

Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions

M. Sibila, G. Guevara, R. Cuadrado, P. Pleguezuelos, D. Pérez, A. Pérez de Rozas, E. Huerta, A. Llorens, O. Valero, M. Pérez, C. López, R. Krejci and J. Segalés

Comparison-of-Mycopl (1.08 MB)Download

Related Services

Ceva Lung Program


From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.